A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

Clinical trial NCT01999582 · COMPLETED

Trial details

NCT number: NCT01999582
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia Kidney Failure, Chronic

Start date: 2013-11-30
Primary completion: 2016-08-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.